drugset / Trial / NCT03349684
Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To demonstrate the efficacy and safety of acarbose and metformin loose-dose combination as compared to metformin monotherapy in the treatment of subjects with T2DM that is inadequately controlled by metformin alone
Timeline
- Start
- 2018-03-05
- Primary completion
- 2019-08-12
- Completion
- 2019-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | 150 mg | Oral |
| Background | Metformin | Small molecule | 500 mg | Oral |